Glenn G. Coleman's most recent trade in Premier Inc - Ordinary Shares - Class A was a trade of 143,475 Class A Common Stock done . Disclosure was reported to the exchange on Nov. 11, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Premier Inc - Ordinary Sha... | Glenn G. Coleman | CAO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2024 | 143,475 | 143,475 (0%) | 0% | 0 | Class A Common Stock | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2024 | 375 | 89,767 (0%) | 0% | 0 | Common Stock | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2024 | 12 | 1,892 | - | - | Phantom Stock (Supplemental Executive Retirement Plan) SERP | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2024 | 404 | 89,392 (0%) | 0% | 0 | Common Stock | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2024 | 11 | 1,879 | - | - | Phantom Stock (Supplemental Executive Retirement Plan) SERP | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 302 | 88,751 (0%) | 0% | 0 | Common Stock | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 9 | 1,868 | - | - | Phantom Stock (Supplemental Executive Retirement Plan) SERP | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 1,858 | 1,858 | - | - | Phantom Stock (Supplemental Executive Retirement Plan) SERP | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 62,800 | 62,800 | - | - | Stock Option (Right to Buy) | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 18,780 | 88,449 (0%) | 0% | 0 | Common Stock | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.27 per share. | 01 Mar 2024 | 1,683 | 69,669 (0%) | 0% | 33.3 | 55,993 | Common Stock |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 193 | 71,352 (0%) | 0% | 0 | Common Stock | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.36 per share. | 22 Nov 2023 | 2,461 | 71,105 (0%) | 0% | 31.4 | 77,177 | Common Stock |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Purchase of securities on an exchange or from another person at price $ 29.70 per share. | 20 Nov 2023 | 10,000 | 73,566 (0%) | 0% | 29.7 | 297,000 | Common Stock |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.32 per share. | 15 Nov 2023 | 2,385 | 63,566 (0%) | 0% | 29.3 | 69,928 | Common Stock |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2023 | 268 | 65,951 (0%) | 0% | 0 | Common Stock | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 228 | 65,683 (0%) | 0% | 0 | Common Stock | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 231 | 65,369 (0%) | 0% | 0 | Common Stock | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 49,700 | 49,700 | - | - | Stock Option (Right to Buy) | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 16,133 | 65,137 (0%) | 0% | 0 | Common Stock | |
DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 378 | 49,004 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.00 per share. | 01 Jul 2022 | 6,666 | 34,622 (0%) | 0% | 55 | 366,630 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 66.04 per share. | 04 Apr 2022 | 6,268 | 41,288 (0%) | 0% | 66.0 | 413,939 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 20,023 | 20,023 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 7,119 | 64,578 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 5,338 | 47,556 (0%) | 0% | 65.1 | 347,557 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 3,706 | 59,765 (0%) | 0% | 65.1 | 241,298 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 2,902 | 52,894 (0%) | 0% | 65.1 | 188,949 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,770 | 57,995 (0%) | 0% | 65.1 | 115,245 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,424 | 55 (0%) | 0% | 65.1 | 92,717 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,107 | 63,471 (0%) | 0% | 65.1 | 72,077 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 775 | 57,220 (0%) | 0% | 65.1 | 50,460 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 12,576 | 57,459 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 10,837 | 44,883 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 5,892 | 34,046 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 74.00 per share. | 02 Nov 2021 | 4,275 | 27,781 (0%) | 0% | 74 | 316,350 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.41 per share. | 16 Apr 2021 | 25,658 | 57,714 (0%) | 0% | 19.4 | 498,022 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2021 | 25,658 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 71.50 per share. | 16 Apr 2021 | 25,658 | 32,056 (0%) | 0% | 71.5 | 1,834,547 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 70.50 per share. | 14 Apr 2021 | 4,002 | 32,056 (0%) | 0% | 70.5 | 282,141 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 09 Apr 2021 | 12,500 | 36,058 (0%) | 0% | 70 | 875,000 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2021 | 12,500 | 25,658 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.41 per share. | 09 Apr 2021 | 12,500 | 48,558 (0%) | 0% | 19.4 | 242,625 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 68.50 per share. | 29 Mar 2021 | 12,500 | 36,058 (0%) | 0% | 68.5 | 856,250 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.41 per share. | 29 Mar 2021 | 12,500 | 48,558 (0%) | 0% | 19.4 | 242,625 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2021 | 12,500 | 38,158 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 68.50 per share. | 29 Mar 2021 | 3,000 | 36,058 (0%) | 0% | 68.5 | 205,500 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 20,518 | 20,518 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 6,807 | 41,086 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 990 | 40,096 (0%) | 0% | 68.1 | 67,419 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 523 | 39,573 (0%) | 0% | 68.1 | 35,616 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 515 | 39,058 (0%) | 0% | 68.1 | 35,072 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 56.03 per share. | 13 Nov 2020 | 2,600 | 33,894 (0%) | 0% | 56.0 | 145,666 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 54.34 per share. | 09 Nov 2020 | 4,907 | 40,987 (0%) | 0% | 54.3 | 266,668 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 56.04 per share. | 09 Nov 2020 | 4,400 | 36,494 (0%) | 0% | 56.0 | 246,597 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 55.04 per share. | 09 Nov 2020 | 93 | 40,894 (0%) | 0% | 55.0 | 5,119 | Common Stock |
Integra Lifesciences Holdi... | Glenn G. Coleman | Executive Vice President & COO | Sale of securities on an exchange or to another person at price $ 52.27 per share. | 11 Aug 2020 | 5,000 | 45,894 (0%) | 0% | 52.3 | 261,343 | Common Stock |